PTPRC and renal cell carcinoma: In RCC patients, VISTA is mainly found in CD45-positive cells of hematopoietic and myeloid origins in para- and tumorous tissues (Huang et al. 2020), and TOX is a marker of hematopoietic cells (Wang et al. 2019).